Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
LUXELE MED from Gouvy, company number BE1012515593, closed financial year 2025 with a result of € 70,986 after tax. For that financial year LUXELE MED recorded a gross margin of € 95,549 and equity of € 86,521. Compared with financial year 2024, the result moved from € 14,135 to € 70,986. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.
€ 86,521
▲ € 70,186 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 70,986
▲ € 56,851 vs 2024
Profit after tax over the fiscal year.
€ 96,748
▲ € 86,909 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 800 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 9,498
▼ 35% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 496
▲ € 483 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,612
▲ € 15,665 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 19,295 | € 95,549 | ▲ € 76,254 |
| Profit after taxes | € 14,135 | € 70,986 | ▲ € 56,851 |
| Equity | € 16,335 | € 86,521 | ▲ € 70,186 |
| Total debts | € 20,106 | € 30,218 | ▲ 50% |
| Cash | € 9,839 | € 96,748 | ▲ € 86,909 |
| Retained profit | € 13,335 | € 83,521 | ▲ € 70,186 |
| Dividend | € 800 | € 800 | |
| Balance sheet total | € 36,441 | € 116,739 | ▲ 220% |
Key figures of LUXELE MED, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LUXELE MED?
What happened at LUXELE MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 70,986 (▲ € 56,851 vs 2024). filed late Source: NBB ↗
- Eléna LUXEN became a director. NBB
- New establishment in Gouvy. KBO
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 14,135 profit in 2024 to € 70,986 profit in 2025.
Paid € 22,841 in corporate taxes since 2024.
Best year ever: 2025, with € 70,986 profit.
Paid out € 1,600 in dividends to the owners in total.
Management
Behind LUXELE MED is Eléna LUXEN.
Directors
According to the 2025 annual accounts
Eléna LUXEN
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Baclain 2
6674 Gouvy
Boulevard de Patience et Beaujonc 2
4000 Liège
Active since 14 August 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1012.515.593
- VAT number
- BE 1012.515.593
- Registered office
- Baclain 2, 6674 Gouvy
- Names & denominations
- LUXELE MED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 August 2024
- Peppol
- Not registered